Cencora Inc. (COR)
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $64.71B
- P/E (TTM)
- 18.89
- Forward P/E
- 15.60
- EPS (TTM)
- $17.95
- Dividend yield
- 0.71% ($2.40)
- Ex-dividend date
- Nov 13, 2026
- 52-week range
- 244.82 – 377.54
- Day range
- 337.88 – 348.57
- Volume / Avg
- 1.23M / 1.29M
- Beta
- —
- Shares outstanding
- 190.83M
52-week range
COR stock today
Shares of Cencora (COR) finished lower on Nov 20 at $339.09, a drop of 0.63% or $2.16 per share, versus the S&P 500's 3.70% decline. At this level, COR sits in the middle of its 52-week range of $244.82 to $377.54: 10.2% below the high, set on Nov 25, 2025 and 38.5% above the low. COR is up 0.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 7.3%.
At 18.9x trailing earnings, Cencora trades below the peer-group median of 27.6x. Its forward P/E of 15.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Cencora pays an annual dividend of $2.40 per share, a 0.71% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Cencora
Company profileCencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Dr. Robert P. Mauch Ph.D., PharmD
- Headquarters
- Conshohocken, PA
- Employees
- 47,000
- Website
- cencora.com
Financial highlights
Full financialsIn fiscal 2025, Cencora generated $321.33 billion in revenue, up 9.3% from fiscal 2024, its 13th consecutive year of revenue growth. Net income was $1.55 billion (+3.0% year over year), for a net margin of 0.5% versus a median of 0.7% in the prior 5 years. Gross margin was 3.6% (up from 3.4%) and operating margin 0.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Growth | +9.31% | +12.12% | +9.89% | +11.50% | +12.69% |
| Net income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| EPS (diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$382.42+12.78%
- Strong buy 3
- Buy 7
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $3.84 vs $4.56
- Surprise
- -15.79%
Dividends
Dividend history- Annual dividend
- $2.40
- Dividend yield
- 0.71%
- Last payment
- $0.66
- Ex-dividend date
- Nov 13, 2026
COR news
All COR news- Here's Why You Should Retain Cencora Stock in Your Portfolio for NowNasdaqCOR, ISRG, WST, GKOS
- FTC Sues To Block Covetrus' $3.5 Bln Acquisition Of MWI Veterinary SupplyNasdaqCOR, BIO.B
- US FTC sues to block Cencora’s $3.5 billion sale of veterinary unit to CovetrusInvesting.com
- TCAF, CNP, COR, ASND: ETF Outflow AlertNasdaqTCAF, CNP, COR, ASND
- 3 Stocks in Focus That Hiked Dividends Amid Ongoing Market VolatilityNasdaqBDX, COR, UNF
- What Cencora (COR) Said on Its Q4 Earnings CallNasdaq
- Cencora (COR) Q4 2026 Earnings Call TranscriptNasdaq
- Cencora, Inc. (COR) Q4 2026 Earnings Call TranscriptSeeking Alpha
Cencora peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CAHCardinal Health Inc. | 272.81 | +0.17% | $63.06B | vs COR |
| MCKMcKesson Corporation | 1,069.43 | +0.68% | $123.47B | vs COR |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs COR |
| NUSNu Skin Enterprises Inc. | 3.80 | +0.80% | $184.98M | vs COR |
| ESYNEnerSyn Global Inc. | 1.11 | -0.89% | $37.44M | vs COR |
| COSMCosmos Health Inc. | 2.81 | -2.09% | $14.14M | vs COR |
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs COR |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs COR |
Indexes, lists and sector
Cencora stock FAQ
What is Cencora's stock price today?
COR last traded at $339.09 as of Nov 20, 4:00 PM EST, down 0.63% on the day. Prices are delayed at least 15 minutes.
Does Cencora pay a dividend?
Yes. Cencora pays $2.40 per share annually, a 0.71% yield. The most recent dividend of $0.66 had an ex-dividend date of Nov 13, 2026.
What is COR's P/E ratio?
COR trades at a trailing P/E ratio of 18.89 and a forward P/E of 15.60, compared with a median of 27.6 for its closest peers.
Is Cencora in the S&P 500?
Yes. Cencora (COR) is a constituent of the S&P 500 index.
Who is Cencora's CEO?
Dr. Robert P. Mauch Ph.D., PharmD is the chief executive officer of Cencora Inc., which has about 47,000 employees.
Has COR ever split its stock?
Yes. The most recent COR stock split was a 2-for-1 split on Jun 16, 2009, one of 3 splits on record.
What is the COR 52-week high?
The 52-week high for COR is $377.54 and the 52-week low is $244.82. The stock is currently 10.2% below its high.